$100.9 Million
SeaSpine Holdings Corporation
Confidentially Marketed Follow-On Offering
Left Bookrunner
$56.5 Million
Marker Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$69.1 Million
Avita Medical Limited
Confidentially Marketed Follow-On Offering
Left Bookrunner
$91.7 Million
Infinity Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$40.6 Million
OncoCyte Corporation
Confidentially Marketed Follow-On Offering
Left Bookrunner
$69.4 Million
Kaleido Biosciences
Confidentially Marketed Follow-On Offering
Active Bookrunner
$86.3 Million
Neuronetics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$75.6 Million
Syros Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$50.6 Million
Fulcrum Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$79.8 Million
Itamar Medical
Confidentially Marketed Follow-On Offering
Left Bookrunner
Subscribe to Equity Capital Markets

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.